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Poxviruses are large DNA viruses that replicate in the cytoplasm of infected cells. Myxoma virus is a rabbit
poxvirus that belongs to the Leporipoxvirus genus. It causes a lethal disease called myxomatosis in European
rabbits but cannot sustain any detectable infection in nonlagomorphs. Vaccinia virus is a prototypal orthopox-
virus that was used as a vaccine to eradicate smallpox. Myxoma virus is nonpathogenic in mice, whereas
systemic infection with vaccinia virus can be lethal even in immunocompetent mice. Plasmacytoid dendritic
cells (pDCs) are potent type I interferon (IFN)-producing cells that play important roles in antiviral innate
immunity. How poxviruses are sensed by pDCs to induce type I IFN production is not well understood. Here
we report that infection of primary murine pDCs with myxoma virus, but not with vaccinia virus, induces
IFN-, IFN-, tumor necrosis factor (TNF), and interleukin-12p70 (IL-12p70) production. Using pDCs derived
from genetic knockout mice, we show that the myxoma virus-induced innate immune response requires the
endosomal DNA sensor TLR9 and its adaptor MyD88, transcription factors IRF5 and IRF7, and the type I IFN
positive-feedback loop mediated by IFNAR1. It is independent of the cytoplasmic RNA sensing pathway
mediated by the mitochondrial adaptor molecule MAVS, the TLR3 adaptor TRIF, or the transcription factor
IRF3. Using pharmacological inhibitors, we demonstrate that myxoma virus-induced type I IFN and IL-12p70
production in murine pDCs is also dependent on phosphatidylinositol 3-kinase (PI3K) and Akt. Furthermore,
our results reveal that the N-terminal Z-DNA/RNA binding domain of vaccinia virulence factor E3, which is
missing in the orthologous M029 protein expressed by myxoma virus, plays an inhibitory role in poxvirus
sensing and innate cytokine production by murine pDCs.
Plasmacytoid dendritic cells (pDCs) are potent type I inter-
feron (IFN)-producing cells that play critical roles in antiviral
immunity. Human and murine pDCs are present in the blood,
bone marrow, spleen, lymph nodes, and various other tissues
(2, 7, 9, 40). pDCs express endosomal localized receptors
TLR7 and TLR9 to detect viral RNA and DNA. Upon ligand
binding, these receptors utilize a coadaptor molecule, MyD88,
to form complexes resulting in the recruitment and activation
of transcription factors, leading to the production of type I IFN
and proinflammatory cytokines (22).
Type I IFNs are critical for antiviral immunity. Type I IFNs
induce DC maturation and immune cell recruitment to sites of
infection and enhance the effector functions of NK, T, and B
cells and macrophages. Through binding to the type I IFN
receptor, a heterodimeric molecule consisting of IFNAR1 and
IFNAR2, type I IFNs activate the JAK-Stat pathway to trigger
an antiviral state. Type I IFN pathways are frequently targeted
for subversion by viral immune modulators. For example, the
vaccinia virus B18R gene encodes a soluble type I IFN recep-
tor. A deletion mutant lacking B18R is attenuated in a murine
intranasal infection model (44). The vaccinia virus E3L gene
encodes an intracellular protein, composed of an N-terminal
Z-DNA/RNA binding domain (ZBD) and a C-terminal dou-
ble-stranded RNA (dsRNA) binding domain (RBD), that an-
tagonizes host sensing of viral nucleic acids and the induction
of type I IFN (11, 12, 52). The ZBD and RBD of the E3
protein are required for vaccinia pathogenesis in a murine
intranasal model (6).
Myxoma virus is a rabbit-specific poxvirus that belongs to the
Leporipoxvirus genus. It causes a rapidly disseminating lethal
myxomatosis in European rabbits (Oryctolagus cuniculus) and a
benign localized infection in its natural evolutionary host in
South American rabbits (Sylvilagus brasiliensis) but is non-
pathogenic in humans and mice. In contrast, systemic infection
with vaccinia virus is lethal in mice, and even vaccination
* Corresponding author. Mailing address: Dermatology Service, De-
partment of Medicine, Memorial Sloan-Kettering Cancer Center, 1275
York Ave., New York, NY 10065. Phone: (212) 610-0785. Fax: (646)
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through skin scarification can produce severe clinical compli-
cations in immunocompromised humans. We suspect that type
I IFN and proinflammatory cytokine induction by myxoma
virus and vaccinia virus might be different in host immune cells
from the same species. This is supported by our recent findings
that infection of human primary pDCs with myxoma virus, but
not vaccinia virus, induces IFN- and tumor necrosis factor
(TNF) production (H. Cao, P. Dai, H. Li, W. Wang, F. Wang,
J. Yuan, J. Liu, R. C. Condit, G. McFadden, J. W. Young, S.
Shuman, and L. Deng unpublished data). To understand the
mechanisms through which myxoma virus is sensed in murine
pDCs, we utilized primary cells derived from genetic knockout
mice that have deficiencies in molecules/pathways important
for viral sensing and type I IFN induction. We found that
TLR9 and MyD88 are required for the induction of type I IFN
by myxoma virus in murine pDCs. The transcription factors
IRF5/IRF7 and IFNAR1 that mediate the type I IFN positive-
feedback loop are also essential for this induction. Our results
define an important pathway in sensing myxoma virus infection
and the induction of type I IFN in murine pDCs. These find-
ings have relevance in the understanding of poxvirus patho-
genesis in various host species and have significant ramifica-
tions for the development of poxviruses as oncolytic viruses
and vaccine vectors.
MATERIALS AND METHODS
Viruses and cell lines. The WR strain of vaccinia virus was propagated, and the
titers of the virus were determined in BSC40 (African green monkey kidney
cells) monolayers at 37°C. The E3L, E3L83N, E3L26C, E3LY48A viruses
were kindly provided by B. L. Jacobs (Arizona State University). E3L and
E3L26C viruses were propagated in BHK-21 (baby hamster kidney) cells, and
the titers of the viruses were determined on RK13 (rabbit kidney) cells.
E3L83N and E3LY48A viruses were propagated, and the titers were deter-
mined on BSC40 cells. The tyrosine-to-alanine change at amino acid 48 of the E3
protein in E3LY48A virus was verified by PCR amplification of the E3 gene,
followed by sequencing analysis. Recombinant myxoma virus (Lausanne strain)
with a cassette expressing green fluorescent protein (GFP) under the control of
a vaccinia virus synthetic early/late promoter inserted between myxoma virus
genes M135R and M136R was propagated, and the titers of the virus were
determined on RK13 cells. BSC40 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum (FBS).
BHK-21 and RK13 cells were cultured in DMEM containing 10% FBS, 0.1 mM
nonessential amino acids, and 50 g/ml gentamicin. All cells were grown at 37°C
in a 5% CO2 incubator.
Mice. Female C57B/6 mice between 6 and 10 weeks of age were purchased
from the Jackson Laboratory and were used for the preparation of bone marrow-
derived dendritic cells. These mice were maintained in the animal facility at the
Sloan-Kettering Cancer Institute. All procedures were performed with the con-
sent of the Institutional Animal Care and Use Committee. MAVS/, IRF3/,
TLR3/, MyD88/, TLR9/, TLR7/, and TRIF/ (TRIFLPS2/LPS2) mice
were generated in the laboratories of Zhijian Chen (University of Texas South-
western Medical Center), Tadatsugu Taniguchi (University of Tokyo), Richard
Flavell (Yale University), Shizuro Akira (Osaka University), and Bruce Beutler
(Scripps Research Institute). IFNAR1/ mice were provided by Eric Pamer
(Sloan-Kettering Institute); the mice were purchased from B&K Universal and
were backcrossed with C57B/6 mice for more than five generations. The
TLR7/ and IRF5/ mice were maintained at the animal facilities at the Johns
Hopkins University School of Medicine. The IRF7/ mice were maintained at
the animal facilities at the University of Massachusetts Medical School.
Generation of bone marrow-derived dendritic cells. The bone marrow cells
from the tibiae and femurs of mice were collected by first removing muscles from
the bones and then flushing the cells out using 0.5 ml U-100 insulin syringes
(Becton Dickinson) with RPMI medium with 10% fetal calf serum (FCS). After
centrifugation, cells were resuspended in ACK lysing buffer (Lonza) for red
blood cell lysis by incubating the cells on ice for 1 to 3 min. Cells were then
collected, resuspended in fresh medium, and filtered through a 40-m cell
strainer (BD Biosciences). The number of cells was counted. For the generation
of fms-like tyrosine kinase-3 ligand-cultured murine bone marrow-derived den-
dritic cells (Flt3L-BMDCs), the bone marrow cells (5  106 cells in each well of
6-well plates) were cultured in the presence of Flt3L (100 ng/ml; R&D Systems)
for 7 to 9 days. Cells were fed every 2 to 3 days by replacing 50% of the old
medium with fresh medium. For the generation of granulocyte-macrophage
colony-stimulating factor (GM-CSF)-BMDCs, the bone marrow cells (5  106
cells in each 10-cm cell culture dish) were cultured in the presence of GM-CSF
(30 ng/ml, produced by the Monoclonal Antibody Core facility at the Sloan-
Kettering Institute) for 10 to 12 days. Cells were fed every 2 days by replacing
50% of the old medium with fresh medium and replated every 3 to 4 days to
remove adherent cells. Only nonadherent cells were used for experiments.
RNA isolation and real-time PCR. RNA was extracted from whole-cell lysates
with an RNeasy minikit (Qiagen) and reverse transcribed with a First Strand
cDNA synthesis kit (Fermentas). Quantitative real-time PCR was performed in
triplicate with iQ SYBR green Supermix and an iCycler iQ thermal cycler and
detection system (Bio-Rad) using gene-specific primers. Relative expression
was normalized to the levels of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
Reagents. The commercial sources for reagents were as follows: CpG oligode-
oxynucleotide ODN2216, InvivoGen; chloroquine, wortmannin, and 3-methylad-
enine, Sigma-Aldrich; AKT inhibitors VIII and X, Calbiochem; murine IFN-/
enzyme-linked immunosorbent assay (ELISA) kits, PBL Biomedical Laborato-
ries; Flt3L, TNF, and interleukin-12p70 (IL-12p70) ELISA kits, R&D systems;
anti-mouse CD11c APC, BD Pharmingen; anti-mouse B220 APC-Cy7 and anti-
mouse PDCA-1 PE, Miltenyi Biotec.
Statistics. Student’s two-tailed t test was used for each pairwise comparison.
The P values deemed significant are indicated in the figures as follows: *, P 
0.05; **, P  0.01; ***, P  0.001.
RESULTS
Myxoma virus but not vaccinia virus infection of Flt3L-
BMDCs induces type I IFN production. To test whether mu-
rine pDCs respond differently to myxoma versus vaccinia virus
infection, we generated Flt3L-BMDCs by culturing bone mar-
row cells in the presence of Flt3L for 7 to 9 days. Flt3L drives
the commitment and differentiation of hematopoietic progen-
itors to the DC lineage (26, 32). In this culture system, we
typically obtain 15 to 25% pDCs and 55 to 65% conventional
DCs (cDCs), as determined by fluorescence-activated cell
sorter (FACS) analysis. Flt3L-BMDCs were either treated with
TLR9 agonist CpG-containing DNA or infected with wild-type
(WT) vaccinia virus or myxoma virus at a multiplicity of infec-
tion (MOI) of 10. Supernatants were collected at 22 h postin-
fection. The levels of secreted IFN-/ and proinflammatory
cytokines were determined by ELISA. We found that CpG
treatment or myxoma virus infection of Flt3L-BMDCs trig-
gered the induction of IFN-/, TNF, and IL-12p70 (the bio-
logically active form of IL-12, composed of p35 and p40 sub-
units [48]), whereas infection with WT vaccinia virus did not
induce the secretion of these cytokines (Fig. 1A). A kinetic
analysis of induced cytokine secretion was performed; this
analysis revealed that IFN-/, TNF, and IL-12p70 were
released into the supernatants at 8 h postinfection with
myxoma virus. The levels of these cytokines continued to
rise and reached plateaus at 12 h postinfection (Fig. 1B). To
determine dose-dependent induction of cytokine secretion
by myxoma virus, we infected Flt3L-BMDCs with myxoma
virus at MOIs ranging from 0.25 to 20. We found that the
maximum induction of cytokine secretion occurred at an
MOI of 1 to 10 (Fig. 1C).
Using GFP-expressing (under the control of vaccinia p7.5
promoter) vaccinia and myxoma viruses, we estimated the ef-
ficiencies of infection based on the percentage of GFP-positive
cells using FACS analysis. In GFP-vaccinia virus-infected
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pDCs, about 50% of cells were GFP positive, whereas in GFP-
myxoma virus-infected pDCs, about 20% of cells were GFP
positive (data not shown). DAPI (4,6-diamidino-2-phenylin-
dole) staining was used to determine cell death. We observed
that 8 to 10% of mock-infected cells were DAPI positive after
a 24-h culture in the absence of Flt3L growth factor. In Flt3L-
BMDCs infected with WT vaccinia virus at an MOI of 10 for
24 h, 20 to 25% cells were DAPI positive, whereas 25 to 30%
of cells infected with myxoma virus at an MOI of 10 were
DAPI positive at 24 h postinfection (data not shown).
Myxoma virus induces type I IFN production in murine
pDCs but not in cDCs. Granulocyte-macrophage colony-stim-
ulating factor (GM-CSF)-cultured murine bone marrow-de-
rived dendritic cells (BMDCs) are CD11c	B220 PDCA-1 cDCs.
We observed that myxoma virus infection of GM-CSF-cul-
tured murine BMDCs did not result in the induction of type
I IFN (data not shown), suggesting that the induction of
type I IFN by myxoma virus in Flt3L-BMDCs was mediated
by pDCs but not by cDCs. To verify that, we isolated pDCs
(CD11c	 B220	 PDCA-1	) and cDCs (CD11c	 B220
PDCA-1) from Flt3L-BMDCs to a purity of greater than
98% using FACS. Purified murine pDCs (2  105 cells) and
cDCs (1  106 cells) were treated with CpG or infected with
WT vaccinia or myxoma virus. Mock treatment controls
were included. Myxoma virus induced high levels of IFN-/
in purified murine pDCs but not in cDCs (Fig. 2A and B).
CpG treatment resulted in the induction of IFN-/ in pu-
rified pDCs but only IFN- in cDCs. WT vaccinia virus
infection failed to induce type I IFN production in either
pDCs or cDCs (Fig. 2A and B).
Myxoma virus induces the expression of IFNA4, IFNB, IL-
12p35, and IL-12p40 genes in purified murine pDCs. To test
whether myxoma or vaccinia virus infection of pDCs alters the
gene expression of type I IFN and proinflammatory cytokines,
we performed quantitative real-time PCR analysis of FACS-
purified pDCs infected either with WT vaccinia virus or myx-
oma virus at an MOI of 10 for 3 or 6 h. Mock infection control
was also included. We found that myxoma virus infection in-
creased the expression of IFNA4 (14,000-fold), IFNB (2,500-
fold), IL-12p35 (16-fold), and IL-12p40 (220-fold) at 6 h
postinfection (Fig. 3A to D). In contrast, WT vaccinia virus
infection leads to a much smaller induction of these cytokines,
including IFNA4 (8-fold at 3 h postinfection and 3-fold at 6 h
postinfection), IFNB (6-fold at 3 h postinfection and 1.6-fold at
6 h postinfection), and IL-12p35 (2.5-fold at 3 h postinfection
and 3.5-fold at 6 h postinfection). No induction of gene ex-
pression was observed with IL-12p40 (Fig. 3A to D). These
results indicate that the induced secretion of type I IFN and
IL-12p70 by purified pDCs in response to myxoma virus infec-
tion correlates with upregulation of gene expression. The fail-
ure of WT vaccinia virus-induced secretion of IFN and IL-
12p70 is due to its inability to upregulate these genes at the
transcriptional level.
Myxoma virus induction of type I IFN and IL-12p70 is
abolished in MyD88/ or TLR9/ murine pDCs. pDCs uti-
lize endosomal TLR7 and TLR9 to detect viral single-stranded
RNA (ssRNA) and CpG-containing DNA. MyD88 is a coad-
aptor molecule that mediates TLR7 and TLR9 sensing in
pDCs (13, 16, 29, 30). To test whether TLR7, TLR9, or MyD88
is involved in myxoma virus induction of type I IFN in pDCs,
FIG. 1. Innate immune responses of murine Flt3L-BMDCs to myxoma virus or vaccinia virus infections. Flt3L-BMDCs were generated from
female C57B/6 mice by culturing bone marrow cells in the presence of Flt3L. (A) Cells (1  106) were infected with wild-type vaccinia virus (WT
VAC) or myxoma virus at a multiplicity of infection (MOI) of 10 for 1 h. A mock-infected control (no virus) was included. Alternatively, cells were
stimulated with TLR9 agonist CpG 2216 (10 g/ml). Supernatants were collected 22 h later, and the concentrations of IFN-, IFN-, TNF, and
IL-12p70 were determined by ELISA. Data are means 
 standard errors of the means (SEM). The experiment was repeated at least twice, and
the results of a representative are shown. (B) Cells (1  106) were infected with myxoma virus at an MOI of 10. Supernatants were collected at
1, 4, 8, 12, or 22 h postinfection. The concentrations of IFN-, IFN-, TNF, and IL-12p70 were determined by ELISA. Data are means 
 SEM.
A representative experiment is shown and repeated at least twice. (C) Cells (1  106) were infected with myxoma virus at increasing MOIs ranging
from 0.25 to 10. Supernatants were collected at 22 h postinfection. The concentrations of IFN-, IFN-, TNF, and IL-12p70 were determined by
ELISA. Data are means 
 SEM. The experiment was repeated once, and the results of a representative are shown.
FIG. 2. Myxoma virus infection of purified murine pDCs induces type I IFN induction. Flt3L-BMDCs were sorted using FACS to purify pDCs
and cDCs to high purity (98%). pDCs (2  105) (CD11c	 B220	 PDCA-1	) and cDCs (1  106) (CD11c	 B220 PDCA-1) were stimulated
with CpG or infected with either WT VAC or myxoma virus at an MOI of 10. Supernatants were collected at 22 h postinfection. The concentrations
of IFN- (A) and IFN- (B) were determined by ELISA. Data are means 
 SEM. The experiment was repeated at least twice, and the results
of a representative are shown.
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we purified pDCs from Flt3L-BMDCs from MyD88/,
TLR9/, TLR7/, or WT control mice by FACS as de-
scribed above. Cells were then treated with CpG or infected
with myxoma virus at an MOI of 10. We found that the induc-
tion of IFN-/ and IL-12p70 by CpG was abolished in
MyD88/ or TLR9/ murine pDCs but not affected in
TLR7/ pDCs (Fig. 4A to C). Myxoma virus-induced pro-
duction of IFN- and IFN- was also abolished in MyD88/
or TLR9/ murine pDCs but only modestly reduced in
TLR7/ pDCs (Fig. 4A and B). We found that neither IL-
12p70 nor TNF induced by myxoma virus was affected in
TLR7/ pDCs. Taken together, these results indicate that
myxoma virus infection in murine pDCs is sensed through a
TLR9/MyD88-dependent pathway. In contrast, TLR7 plays a
minor role.
Myxoma virus induction of type I IFN in murine pDCs is
independent of MAVS, TRIF, or IRF3. We assessed the con-
tributions of other known signaling pathways to the induction
of type I IFN by myxoma virus. MAVS (mitochondrial antiviral
signaling protein), also known as IPS-1, VISA, or Cardif, is an
adaptor for cytosolic RNA sensors RIG-I and MDA5. TRIF
(TIR-domain-containing adaptor-inducing beta interferon) is
an adaptor for the endosomal TLR3 that senses extracellular
dsRNA (1, 22). IRF3 (interferon regulatory factor 3) is an
essential transcription factor for the regulation of type I IFN
expression in many cell types except pDCs (18, 37). We in-
fected Flt3L-BMDCs from MAVS/, TRIF/, IRF3/,
and WT control mice with myxoma virus at an MOI of 10.
Supernatants were collected at 22 h postinfection. We found
that MAVS-, TRIF-, or IRF3-deficient cells produced amounts
of type I IFN similar to those of control WT pDCs in response
to myxoma virus infection (Fig. 5). This result is consistent with
previous findings that MAVS, TRIF, or IRF3 is not involved in
type I IFN induction in pDCs (18, 43, 53).
Transcription factors IRF5 and IRF7 are required for the
induction of type I IFN in murine pDCs by myxoma virus. The
interferon regulatory factors IRF5 and IRF7 are transcription
factors that are critical for host defense against viral infections
(18, 54). IRF5-deficient mice had increased susceptibility to
vesicular stomatitis virus (VSV) and herpes simplex virus 1
(HSV-1) infections and produced lower levels of IFN-/ and
IL-6 than WT control mice in vivo (54). IRF5/ macrophages
produced lower levels of these cytokines than WT cells in
response to VSV and HSV-1 infections. However, IRF5/
murine embryonic fibroblasts (MEFs) produced amounts of
these cytokines similar to those of WT cells, indicating that the
contribution of IRF5 to type I IFN and IL-6 production is cell
type specific. IRF7/ mice are highly susceptible to encepha-
lomyocarditis virus (EMCV) and HSV-1 infections, with mark-
edly reduced levels of IFN- in the serum. IRF7/ pDCs
failed to produce IFN- in response to TLR7 or TLR9 stim-
ulation (18). To test whether the transcription factors IRF5
and IRF7 are required for the induction of type I IFN in
murine pDCs by myxoma virus infection, we generated Flt3L-
BMDCs from IRF5/, IRF7/, or WT control mice and
purified pDCs by FACS. We then infected these cells with
myxoma virus at an MOI of 10 or treated them with CpG.
Supernatants were collected at 22 h postinfection, and the
secreted cytokine levels were determined by ELISA. We found
that type I IFN, TNF, and IL-12p70 induction by myxoma virus
or CpG was abolished or significantly reduced in IRF5- or
IRF7-deficient pDCs (Fig. 6A and B). These results indicate
FIG. 3. Myxoma virus infection of purified murine pDCs induces the expression of IFNA4, IFNB, IL-12p35, and IL-12p40 genes. FACS-sorted
pDCs (5  105) were infected with either WT VAC or myxoma virus at an MOI of 10. Cells were collected at 3 or 6 h postinfection. Real-time
PCR analysis of IFNA4 (A), IFNB (B), IL-12p35 (C), and IL-12p40 (D) mRNAs was performed. Data are means 
 SEM. The experiment was
repeated twice, and the results of a representative are shown.
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that IRF5 and IRF7 are both required for the induction of the
expression of IFN-/, TNF, and IL-12p70 in murine pDCs in
response to myxoma virus infection or to CpG stimulation.
The IFN positive-feedback loop is essential for the induction
of type I IFN in murine pDCs by myxoma virus. Type I IFNs
secreted by virus-infected cells can act in an autocrine or para-
crine manner through binding to the type I IFN receptor
(IFNAR1) to stimulate the JAK-Stat pathway, resulting in the
upregulation of IFN-responsive genes. Infection of murine em-
bryonic fibroblasts with Newcastle disease virus (NDV) trig-
gered upregulation of IRF7 expression, which was abolished in
IFNAR1/ cells (36) or in Stat1/ cells (31). The induction
of IFN- by TLR9 agonist CpG was abolished in IFNAR1/
pDCs in response to CpG stimulation (18). To test whether
this positive-feedback loop plays a role in type I IFN induction
by myxoma virus, we obtained highly purified pDCs from
Flt3L-BMDC cultures generated from IFNAR1/ mice and
WT controls. We found that IFN-/, TNF, and IL-12p70
induction by myxoma virus was abolished in IFNAR1/ pDCs
(Fig. 6C). This shows that the positive-feedback loop mediated
FIG. 4. Myxoma virus induction of type I IFN, TNF, and IL-12p70 in murine pDCs requires TLR9/MyD88. Purified murine pDCs were
obtained using FACS from Flt3L-BMDCs generated from MyD88/ (A), TLR9/ (B), and TLR7/ (C) mice and their age-matched WT
controls. pDCs (2  105) were stimulated with CpG or infected with myxoma virus at an MOI of 10. Supernatants were collected 22 h later. The
concentrations of IFN-/, IL-12p70, and TNF were determined by ELISA. Data are means 
 SEM. The combined results of three independently
performed experiments are shown. **, P  0.01; ***, P  0.001; ns, nonsignificant (comparisons were made between WT cells and various
knockout cells as indicated).
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by IFNAR1 is required for the induction of type I IFN, TNF,
and IL-12p70 by myxoma virus in murine pDCs.
Type I IFN induction in murine pDCs by myxoma virus can
be blocked by pharmacological inhibitors. Chloroquine blocks
endosomal/lysosomal acidification and thereby might affect
myxoma virus sensing through TLR9, which is localized in the
endosomal compartment. We infected Flt3L-BMDCs with
myxoma virus at an MOI of 10. At 1 h postinfection, cells were
treated with chloroquine at final concentrations of 1, 10, and
100 M. Supernatants were collected at 18 h postinfection and
measured for the concentrations of IFN-/ and IL-12p70 by
ELISA. We observed a dose-dependent inhibition of IFN-/
and IL-12p70 in the presence of chloroquine (Fig. 7A). To
probe whether the PI3K/Akt signaling pathway plays a role in
the induction of type I IFN by myxoma virus, we infected
Flt3L-BMDCs with myxoma virus for 1 h and incubated the
cells in fresh medium in the presence of wortmannin and
3-methyladenine. Wortmannin, a furanosteroid metabolite of
the fungus Penicillium funiculosum, is a potent inhibitor of
PI3Ks through covalent modification of the catalytic subunit
of PI3K (34, 51). 3-Methyladenine (3-MA) also inhibits PI3K
(5). To avoid the effects of the drugs on viral entry, wortman-
nin or 3-MA was added at 1 h postinfection. Treatment of
pDCs with wortmannin or 3-MA resulted in a dose-dependent
inhibition of IFN-/ and IL-12p70 production (Fig. 7B and
C). Akt (protein kinase B) is a downstream kinase of PI3K. We
found that treatment with Akt inhibitor VIII and X after viral
entry also blocks the induction of IFN-/ and IL-12p70 in a
dose-dependent manner (Fig. 8A to C).
The N-terminal Z-DNA/RNA binding domain of vaccinia
virus E3 inhibits the induction of IFN-, TNF, and IL-12p70
in murine pDCs by myxoma virus. To test whether vaccinia
virus produces an inhibitor(s) to block poxvirus sensing, we
performed coinfection experiments with purified murine
pDCs. We found that coinfection of pDCs with myxoma virus
and WT vaccinia virus or the E3L83N (in which the N-ter-
minal Z-DNA/RNA binding domain of E3 is deleted),
FIG. 5. Myxoma virus-induced innate immune responses in murine
pDCs are independent of MAVS, TRIF, or IRF3. Flt3L-BMDCs were
generated from MAVS/ (A), TRIF/ (B), and IRF3/ (C) mice
and their age-matched WT controls. FLt3L-BMDCs (1  106) were
infected with myxoma virus. Supernatants were collected 22 h later,
and the concentrations of IFN-/ were determined by ELISA. Data
are means 
 SEM. Results shown are representative of three experi-
ments.
FIG. 6. The interferon regulatory factors IRF5 and IRF7 and the
type I IFN positive-feedback loop mediated by IFNAR1 are required
for myxoma virus-induced innate immune response in murine pDCs.
Purified murine pDCs were obtained using FACS from Flt3L-BMDCs
generated from IRF5/ (A), IRF7/ (B), and IFNAR1/ (C) mice
and their age-matched controls. pDCs (2  105) were infected with
myxoma virus at an MOI of 10. Supernatants were collected 22 h later.
The concentrations of IFN-/, TNF, and IL-12p70 were determined
by ELISA. Data are means 
 SEM. The combined results of three
independently performed experiments are shown. ***, P  0.001
(comparisons were made between WT cells and various knockout cells
as indicated).
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E3LY48A (in which a change of tyrosine residue to alanine in
the Z-DNA/RNA binding domain resulting in reduced
Z-DNA binding affinity), or E3L26C (in which a portion of
the C-terminal dsRNA binding domain is deleted) mutant
abolished the induction of IFN-. In contrast, coinfection of
pDCs with myxoma virus plus E3L virus (in which the full E3
gene is deleted) reduced the induction of IFN- only by 39%.
These results suggest that vaccinia virus E3 can inhibit the
induction of IFN- in murine pDCs by myxoma virus. Either
the N-terminal Z-DNA/RNA binding domain or the C-termi-
nal dsRNA binding domain suffices to block the induction of
IFN-.
A different picture emerged when we examined the produc-
tion of IFN-, TNF, and IL-12p70 in the coinfection experi-
ments. Coinfection of murine pDCs with myxoma virus plus
WT vaccinia virus dramatically reduced the induction of
IFN-, TNF, and IL-12p70. Coinfection of myxoma virus with
E3L or E3L83N vaccinia virus only modestly reduced the
induction of IFN-, TNF, and IL-12p70. In contrast, coinfec-
tion of myxoma virus with E3L26C or E3LY48A vaccinia
virus produced an inhibitory effect similar to coinfection with
WT vaccinia virus (Fig. 9B). These results indicate that the
N-terminal Z-DNA/RNA binding domain of vaccinia virus E3
plays an inhibitory role in the induction of IFN-, TNF, and
IL-12p70 in murine pDCs in response to myxoma virus infec-
tion. We observed similar results when CpG was used in lieu of
myxoma virus, indicating that the Z-DNA/RNA binding do-
main of vaccinia virus E3 mediates the inhibition of IFN-,
TNF, and IL-12p70 induction by a bona fide TLR9 agonist
(Fig. 9A). We surmise that the Z-DNA/RNA binding domain
of vaccinia virus E3 might interfere with poxviral DNA sensing
and that the Z-DNA binding activity of the domain per se is not
required for this inhibitory effect.
DISCUSSION
The present study provides insight into how poxviruses are
sensed by murine pDCs, a specialized subset of DCs that are
important for type I IFN induction and antiviral immunity. We
show that myxoma virus induces type I IFN, TNF, and IL-
12p70 in murine pDCs and that the induction is dependent on
TLR9/MyD88. The transcription factors IRF5 and IRF7 are
required for this induction. Furthermore, the type I IFN feed-
back loop is critical for the induction, as IFNAR1-deficient
pDCs fail to produce type I IFN in response to myxoma virus
infection. In contrast, vaccinia virus infection of murine pDCs
fails to induce type I IFN. Our results demonstrate that myx-
oma virus infection can be sensed in murine pDCs by endo-
FIG. 7. Chloroquine, wortmannin, and 3-methyladenine block the induction of IFN-/ and IL-12p70 in murine BMDCs by myxoma virus.
Flt3L-BMDCs (1  106) were infected with myxoma virus at an MOI of 10 for 1 h. Cells were washed and incubated in fresh medium in the
presence or absence of increasing concentrations of chloroquine (A), wortmannin (B), or 3-methyladenine (C). Supernatants were collected 22 h
later. The concentrations of IFN-/ and IL-12p70 were determined by ELISA. Data are means 
 SEM. The combined results of three
independently performed experiments are shown. *, P  0.05; **, P  0.01; ***, P  0.001; ns, nonsignificant (compared with results for no drug
treatment).
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somal TLR9 and induces type I IFN and IL-12p70 production
through a PI3K/Akt-dependent signaling pathway. These
findings may partly explain why myxoma virus is nonpatho-
genic in mice, whereas systemic infection with vaccinia virus
can be lethal in either immunocompetent or immunodefi-
cient mice.
Wang et al. (49) demonstrated that type I IFN induction by
myxoma virus in primary mouse embryonic fibroblasts (MEFs)
mediates cellular restriction of myxoma virus replication in
these cells. Myxoma virus infection becomes permissive in cul-
tured WT MEFs in the presence of neutralizing antibodies to
type I IFNs or in IFNAR1- or Stat1-deficient MEFs. Further-
more, myxoma virus causes lethality in Stat1/ mice in an
intracranial infection model, highlighting the importance of
the IFN-Stat1 pathway in host defense against poxvirus infec-
tion. How myxoma virus is initially sensed by primary MEFs to
induce type I IFN production is currently unknown. It has been
reported that myxoma virus infection in primary human mac-
rophages induces type I IFN through a cytosolic RNA sensing
pathway mediated by RIG-I (50), but the inherent diversity of
operational pathogen sensors that exist between cells of dif-
FIG. 8. Akt inhibitors block the induction of IFN-/ and IL-12p70
in murine BMDCs by myxoma virus. Flt3L-BMDCs (1  106) were
infected with myxoma virus at an MOI of 10 for 1 h. Cells were washed
and incubated in fresh medium in the presence or absence of increas-
ing concentrations of Akt inhibitor VIII or X. Supernatants were
collected 22 h later. The concentrations of IFN- (A), IFN- (B), and
IL-12p70 (C) were determined by ELISA. Data are means 
 SEM.
The combined results of three independently performed experiments
are shown. *, P 0.05; **, P 0.01; ***, P 0.001; ns, nonsignificant
(compared with results for no drug treatment). FIG. 9. The induction of IFN-/, TNF, and IL-12p70 in murine
pDCs by CpG or myxoma virus is attenuated by vaccinia virus E3.
(A) Purified murine pDCs (2  105) were stimulated with CpG alone
or infected with WT vaccinia virus or E3L, E3L83N, E3LY48A, or
E3L26C mutant virus followed by the addition of CpG. (B) Purified
murine pDCs (2  105) were infected with myxoma virus alone at an
MOI of 10 or coinfected with myxoma virus and equal amounts of WT
vaccinia virus or E3L, E3L83N, E3LY48A, or E3L26C mutant
virus. Supernatants were collected 22 h later. The concentrations of
IFN-, IFN-, TNF, and IL-12p70 were determined by ELISA. Data
are means 
 SEM. The combined results of three independently
performed experiments are shown. *, P 0.05; **, P 0.01; ***, P
0.001; ns, nonsignificant (compared with results for CpG treatment
alone [A] or myxoma virus infection alone [B]).
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ferent lineages suggests caution in extrapolating these results
to other cell types.
In this study, we focused our attention on murine pDCs
because of their potency in the induction of type I IFN in
response to virus infection. Both human and murine pDCs
utilize endosomal TLR7 and TLR9 to sense ssRNA and viral
DNAs. TLR9/MyD88 is important for the induction of type I
IFN in pDCs in response to herpes simplex virus 1 and 2
(HSV-1 and HSV-2) (24, 29, 17). TLR9/MyD88 is also re-
quired for the induction of cytokine responses in pDCs and NK
cell activation in response to mouse cytomegalovirus (MCMV)
infection, and it is essential for host defenses against MCMV
infection (25, 45). Ectromelia virus (the causative agent of
mousepox) activates murine pDCs through TLR9 (35). Mice
with TLR9 deficiency are more susceptible to ectromelia virus
infection (35). Here we show that the induction of type I IFN
in murine pDCs by myxoma virus requires TLR9/MyD88.
TLR7 is critical for sensing RNA viruses such as vesicular
stomatitis virus and influenza virus in pDCs (13, 30). It also
plays a compensatory role in host defense against MCMV in
vivo (56). Our results demonstrate that TLR7 plays a minor
role in sensing myxoma virus in murine pDCs in vitro.
Type I IFN is a critical mediator of antiviral innate immu-
nity. The interferon regulator factors IRF3, IRF5, and IRF7
play important roles in the regulation of type I IFN genes.
IRF3 is constitutively expressed in all cell types, whereas the
constitutive expression of IRF7 is restricted to cells of lym-
phoid origin but can be induced in most cell types by type I IFN
(3, 31). IRF3 is required for type I IFN induction triggered by
TLR3/TLR4, cytosolic RNA sensing mechanisms mediated by
RIG-I/MDA5/MAVS, or cytosolic DNA sensing pathway in
many cell types, including cDCs, but it is not required for type
I IFN induction in pDCs (8, 14, 19, 20, 42, 43, 55). It has been
proposed that IRF3 plays essential roles in both early and late
phases of IFN-/ gene induction, whereas IRF7 is more im-
portant for the late induction phase (28, 37). IRF7 has been
shown to form complexes with MyD88 and TRAF6 upon
TLR7/TLR9 stimulation (23).
IRF5 can be activated in response to viral infections, includ-
ing Newcastle disease virus, VSV, and HSV-1, but not Sendai
virus (4). In the initial report on IRF5/ mice by Takaoka et
al. (46), IFN- induction was not affected in the pDCs from
IRF5/ mice in response to CpG stimulation, whereas the
induction of proinflammatory cytokines was impaired (46).
Subsequent studies from the same group showed that IRF5/
mice are more susceptible to VSV or HSV-1 infections. The
IRF5/ mice had reduced serum levels of type I IFN and IL-6
after viral infections (54). Paun et al. (33) reported that
IRF5/ mice are more susceptible to NDV infection, and the
serum levels of IFN-, TNF, and IL-6 were lower in IRF5/
mice than in WT mice in response to NDV infection. IRF5 has
also been shown to be a central mediator of TLR7 signaling
(38). Here we show that both IRF5 and IRF7 are required for
the induction of IFN-/ and IL-12p70 in murine pDCs in-
fected by myxoma virus, whereas IRF3 is dispensable for the
IFN induction. This is consistent with our model that myxoma
virus infection of pDCs leads to the detection of viral DNA by
TLR9 and the activation of transcription factors IRF5 and
IRF7 via MyD88, TRAF6, and other associated factors and
results in the induction of type I IFN, TNF, and IL-12p70,
which are the critical mediators of innate immunity.
The role of the type I IFN positive-feedback loop in the
induction of type I IFN in pDCs in response to TLR stimula-
tion or viral infection is not well understood. Sato et al. (36)
reported that the induction of IRF7 mRNA in mouse embry-
onic fibroblasts in response to Newcastle disease virus (NDV)
was dependent on type I IFN receptor. Marie´ et al. (31) re-
ported that although an immediate-early response gene
(IFNA4) was induced by NDV in fibroblasts in the absence of
the type I IFN positive-feedback loop, secondary induction of
other IFN- subtypes was impaired in the absence of Stat1 or
IFNAR. They also reported that ectopic expression of IRF7 in
fibroblasts led to the induction of the secondary IFN- sub-
types. Conventional DCs produced type I IFN and IL-12p70 in
response to TLR stimulation in a Stat1- and IFNAR-depen-
dent manner (15). The type I IFN positive-feedback loop is
also important for pDC activation in vivo and IFN induction in
vitro in response to CpG stimulation or viral infection (2, 19).
We observed that IFNAR1 is required for the induction of
both IFN-/ and IL-12p70 in pDCs by myxoma virus, sup-
porting the important role of the IFN positive-feedback loop in
the induction and sustaining of antiviral innate immune re-
sponses. Although IRF7 is expressed in pDCs, type I IFN
might be necessary for the enhancement of IRF7 levels.
It is unclear how myxoma viral DNA might be sensed by
endosomally localized TLRs in pDCs. Poxviruses enter host
cells through fusion with the plasma membrane via a large
entry/fusion complex or via a low-pH-dependent endosomal
pathway and subsequent fusion with endosomal membrane to
release the virion cores into the cytoplasm (39, 47). Because
most of the viral entry studies were conducted with vaccinia
virus in various transformed cell lines, little is known about
how myxoma virus enters primary pDCs. If the basic mecha-
nisms of viral entry are preserved among different poxviruses,
we presume that myxoma virion cores are released into the
cytoplasm shortly after viral entry. Some of the virion cores
might then be transported to the endosomal/lysosomal com-
partments where viral DNAs are released and detected by
TLR9. Alternatively, the cores are uncoated in the cytoplasm
and some of the released viral DNA is then taken up and
transported to the endosomes. Our findings that treatment of
pDCs 1 h postinfection with an endosomal/lysosomal acidifi-
cation inhibitor, chloroquine, blocks type I IFN and IL-12p70
induction indicate that endosomal/lysosomal processing of vi-
rions might be important for the detection of viral DNAs
through TLR9. Alternatively, low pH in the endosomes/lyso-
somes might be important for optimal ligand and receptor
interactions. It has been reported that during VSV infection of
pDCs, autophagy plays an important role in the detection of
cytosolic viral replication intermediates by TLR7 (27). We also
observed that treatment of pDCs 1 h postinfection with the
PI3K inhibitors wortmannin and 3-MA blocked the induction
of type I IFN and IL-12p70. Wortmannin and 3-MA have been
used widely as inhibitors of autophagy. Further investigations
on the role of autophagy in poxvirus sensing in pDCs is war-
ranted.
Vaccinia virus E3 is a key viral immunomodulator that in-
hibits type I IFN induction in host cells (12, 41). E3 has two
distinct domains, the N-terminal Z-DNA/RNA binding do-
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main and the C-terminal dsRNA binding domain. Infection of
murine keratinocytes with E3L or E3L26C vaccinia virus
but not with WT vaccinia virus or the E3L83N mutant virus
induces IFN- and related cytokine and chemokine production
in a MAVS/IRF3-dependent manner (12; P. Dai and L. Deng,
unpublished data). This induction effect is dependent on viral
DNA replication, indicating that cytosolic dsRNA produced
postreplicatively is the trigger for the induction of innate im-
mune responses but is targeted by the dsRNA binding domain
of E3 (12). Here we show E3L or E3L26C vaccinia virus
infection of murine pDCs fails to induce type I IFN, TNF, or
IL-12p70 and is less capable of inhibiting type I IFN induction
by myxoma virus infection or CpG stimulation than WT or
E3L83N vaccinia virus, implying that E3L vaccinia virus
infection fails to produce activators in pDCs and the Z-DNA/
RNA binding domain of E3 mediates inhibition of type I IFN
induction in pDCs by myxoma virus or CpG. These results
indicate that both domains of vaccinia virus E3 function to
block innate immune responses in a cell-type-specific fashion.
Significantly, the E3 ortholog expressed by myxoma virus,
M029, has an intact C-terminal dsRNA binding domain but
lacks the N-terminal Z-DNA/RNA binding domain. This dif-
ference may partly explain the immune activating property of
myxoma virus.
A recent study by Delaloye et al. (10) investigated the im-
mune sensing mechanism of modified vaccinia Ankara virus
(MVA) in macrophages that revealed that multiple viral sens-
ing pathways mediate the induction of type I IFN and proin-
flammatory cytokine induction (10). MVA failed to induce
type I IFN induction in purified murine or human pDCs but
induced type I IFN and proinflammatory cytokine and chemo-
kine secretion in cDCs (data not shown). It is possible that
MVA produces an inhibitor(s) that blocks poxviral sensing in
pDCs. The apparent differences in the induction of type I IFN
in pDCs and cDCs between myxoma virus and MVA are in-
teresting and warrant further investigation.
In conclusion, this study provides a molecular and genetic
basis of how poxvirus sensing is mediated in pDCs. We dem-
onstrate that induction of type I IFN and proinflammatory
cytokines in murine pDCs by myxoma virus is mediated by
TLR9/MyD88. In addition to IRF7, transcription factor IRF5
is also required for this induction. We also reveal an important
role of the N-terminal Z-DNA/RNA binding domain of vac-
cinia virus E3 in attenuating poxvirus sensing and TLR9 sig-
naling in pDCs. Our findings that drug inhibitors of PI3K/Akt
signaling pathway block type I IFN and IL-12p70 induction
suggest that PI3K/Akt might be involved in poxvirus sensing in
pDCs. The availability of mice with the TLR and RIG-I-like
receptor (RLR) sensing pathways knocked out and the feasi-
bility of generating various primary cell types using bone mar-
row cells in the in vitro cell culture system allow us to define the
role of various sensors and adaptors in innate immune re-
sponses to poxvirus infection. Once these are clearly defined,
the roles of these relevant innate immune sensors in host
defense against poxvirus need to be examined using in vivo
infection models (21). These studies will aid in developing the
next generations of poxvirus platforms best suited for either
oncolytic virotherapy, where the suppression of innate antiviral
immune pathways is often desired in order to increase the
lifetime of the oncolytic virus in tumors, or vaccine agendas,
where the robust induction of early innate cytokines by DCs is
most beneficial in obtaining maximal immunogenicity of the
desired immunogen.
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ERRATUM
Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid
Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and
IFNAR-Dependent Pathway
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Volume 85, no. 20, p. 10814–10825, 2011. Page 10818, Fig. 3: Delete “(% of control)” from the y axis. The y axis represents
relative mRNA expression compared with no virus control.
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